FIELD: medicine.
SUBSTANCE: invention covers drugs and concerns a combination intended for treating respiratory disease, containing (a) effective amount of corticosteroid, and (b) effective amount of antagonist of muscarine receptors M3 representing (3R)-1-phenethyl-3-(9N-xantene-9-xarbonyloxy)-1-azoniumbicyclo[2.2.2]octane in the form of salt with an anion X which represents a pharmaceutically acceptable anion of mono- or polyvalent acid. There is also disclosed application of (3R)-1-phenethyl-3-(9N-xantene-9-carbonyloxy)-1-azoniumbicyclo[2.2.2]octane and corticosteroid for making a drug for respiratory disease and the method of treating respiratory disease.
EFFECT: improved therapeutic effect in treating respiratory diseases.
20 cl, 1 dwg, 1 tbl, 7 ex
